A World Health Organization (WHO) report has found no adverse health outcomes but rather several medical applications for cannabidiol, a.k.a. CBD, despite U.S. federal policy on this cannabinoid chemical. Experts further stated that CBD, a non-psychoactive chemical found in cannabis, does not induce physical dependence and is “not associated with abuse potential.” The WHO also wrote that, unlike THC, people aren’t getting high off of CBD, either. In fact, evidence suggests that CBD mitigates the effects of THC (whether joyous or panicky), according to this and other reports. The authors pointed out that research has officially confirmed some positive effects of the chemical, however. The WHO team determined that CBD has “been demonstrated as an effective treatment for epilepsy” in adults, children, and even animals, and that there’s “preliminary evidence” that cbd gummies for anxiety relief could be useful in treating Alzheimer’s disease, cancer, psychosis, Parkinson’s disease, and other serious conditions. But the U.S., the report noted, isn’t one of them.

As a cannabis component, CBD remains classified as a Schedule I controlled substance, meaning it has a “high potential for abuse” in the federal government’s view. Nevertheless, the “unsanctioned medical use” of CBD is fairly common, calming hemp product oil benefits experts found. For many CBD users in the U.S., the substance’s mostly unsanctioned and illegal state creates problems, especially as a wave of online (mostly hemp) and store-bought visit TerraPro CBD official site oils and extracts have allowed patients to take the treatment process--and the risks involved in buying unregulated medicine--into their own hands and homes. While CBD itself is safe and found to be helpful for many users, industry experts have warned that not all cannabis extracts are created equally, purely, or with the same methods of extraction. And while reports of negative reactions to pure CBD are very few and far between, researchers are able to say that the cannabinoid wouldn’t be to blame alone. As the cannabis reform nonprofit NORML reported, the WHO is currently considering changing CBD’s place in its own drug scheduling code. In September, NORML submitted written testimony to the U.S. Food and Drug Administration (FDA) opposing the enactment of international restrictions on access to CBD.

If you’re dipping your toes into the infused beverage space, these businesses can help you get started. As cannabis regulation continues to evolve across the United States and around the world, please be mindful of your local laws and regulations. Alcoholism runs deep in both sides of my family. To prevent possibly continuing those patterns as I get older, I’ve become more interested in exploring other options for social drinking